Loding Loading ...
X
Century is regulated by the Capital Market Authority. CFDs are leveraged products that incur a high level of risk. Know more
  • AR AR
Century Financial Consultancy

Portfolio Mix

Click on the dial to see the conservative, moderate & aggressive portfolio strategies.

Asset Allocation
10%
Equities
10%
Indices
10%
Forex
20%
Commodities
50%
Bonds
Note: This is for illustrative purposes only and there is no obligation to accept the asset allocation provided by this tool. The Portfolio Mix is neither investment advice nor a suggestion on asset allocation to be adopted by the investors.
Instruments
Description
Trend
Trading Range
equites
Eli Lilly and
Company
Trend
Range $1,050 - $1,330
Real-world evidence of Zepbound's cost-offset potential unlocks a powerful new growth lever beyond the current financial trajectory. A study of 15,000+ patients showed sustained Zepbound users had healthcare costs up to 38% lower after 12 months (excluding drug price), with savings reaching ~$181 per patient by six months, which nearly offsets the ~$195 monthly Medicare Bridge cost. That data directly addresses payer reluctance and positions Zepbound for significantly broader reimbursement across Medicare, Medicaid, and employers, dramatically expanding its addressable population. This cost-saving narrative complements other powerful catalysts: Foundayo's prescriber base surging to 36,000, Retatrutide's best-in-class 19–28% weight loss profile, and the AtaiBeckley CNS pivot into treatment-resistant depression. All this builds on Q2 revenue of $22.97B (up 48% YoY), with Mounjaro and Zepbound collectively contributing nearly 65% of sales. With about 55% global incretin market share, 93% China growth, and raised FY26 guidance to $85–87B, Lilly's obesity opportunity continues to convert into sustained revenue expansion.
Readmoreless
indeces
Switzerland
20
Trend
Range CHF 13,620 -
CHF 15,080
The Switzerland 20 Index printed a fresh all-time high at CHF14,670 on 11th August, taking YTD gains into double-digit territory, before easing back to test the support of its ascending channel intact since March, with price also holding just above the 14,400 horizontal support that capped the July–August consolidation. The index remains defensively skewed relative to global peers, with healthcare and consumer staples together accounting for the largest share of its weight. Nestlé, Novartis and Roche continue to anchor performance as the allocators increase their preference towards stable, cash-generative franchises. Negligible semiconductor exposure and low oil sensitivity keep the index insulated from AI capex volatility and lingering Middle East risk. With the SNB widely expected to hold at zero at its 24th September assessment and the franc having drifted modestly weaker against the euro over the summer, the pullback to channel support looks constructive rather than distributive, keeping the medium-term uptrend intact.
Readmoreless
forex
AUD/JPY
Trend
Range 109.40 - 119.40
Technically, the currency pair is holding the 114-115 range on the weekly timeframe, supporting a bullish stance. On the daily chart, RSI is above 60, indicating a secular uptrend. From a fundamental standpoint, the Australian Dollar is witnessing massive strength from economic activity. According to the latest data, domestic business activity is expected to remain in expansion territory in August, after advanced PMI prints showed Manufacturing at 52.0 and Services at 52.9. In addition to this, the latest trade balance figures showed an A$1.929 billion surplus in June, reversing May’s A$2.367 billion deficit. Reversing a deficit means Australia is once again a net exporter, meaning foreign buyers must purchase AUD to settle transactions, providing an organic lift to the currency's value. Furthermore, this gives the RBA more leeway to maintain a hawkish stance to combat sticky inflation. The latest Consumer Inflation Expectations rose to 4.9% in August (from 4.7%), according to the Melbourne Institute.
Readmoreless
commodities
Gold
Trend
Range $4,140 - $5,035
Gold has risen to the highest level in three months, propelled higher by the U.S. Treasury’s recent intervention in the bond markets, aimed at easing borrowing costs. The move has brought the “debasement trade” back into focus — the same theme that played a major role in gold’s record-breaking rally last year. The concern is that persistent efforts to manage the growing US debt burden, alongside large fiscal deficits, could gradually undermine confidence in the dollar, encouraging investors to turn to gold as an alternative store of value. Meanwhile, recent data points like the Core PCE Index came in line with expectations, thereby reinforcing the view to maintain rates for now rather than increase. Meanwhile, money managers have also increased their net-long exposure, but holdings remain well below 2024 peaks, leaving scope for further buying. This, in addition to the narrowing spread between the spot and futures curve and resilient central bank purchases, shows gold is being well-supported.
Readmoreless
bonds
iShares Core U.S. Aggregate Bond ETF (AGG)
Trend
Range $97.33 - $97.65
The iShares Core U.S. Aggregate Bond ETF (AGG) is a prominent fund that closely tracks the Bloomberg U.S. Aggregate Bond Index, offering a comprehensive snapshot of the U.S. investment-grade bond market. With a diversified portfolio of over 8,000 bonds, including government, corporate, mortgage-backed, and asset-backed securities, AGG provides extensive coverage of the U.S. bond market. The ETF is designed for cost effciency, with a low expense ratio of 0.03%—well below industry standards—and manages assets exceeding $135.21 billion. AGG has delivered one-year returns of 1.85%, with a 12-month dividend yield of 4.05%. As a result, the ETF provides broad exposure to U.S. bonds at a relatively low cost, with returns that may include income and potential capital appreciation. The ETF has an effective duration of 5.85, making it less sensitive to interest rate fluctuations.
Readmoreless
iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD)
Trend
Range $106.11 - $106.59
The iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) seeks to track the performance of an index comprising U.S. dollar-denominated investment-grade corporate bonds. It gives investors exposure to the high-quality segment of the corporate bond market, offering broad diversification across sectors, maturities, and credit ratings. It has an expense ratio of 0.14% and good liquidity. The fund has delivered a 1-year return of 0.97%. The ETF has a 12-month dividend yield of 4.66%. It carries moderate interest rate risk and low credit risk, with most holdings rated A or higher by major credit rating agencies. LQD may suit investors seeking diversified exposure to the investment-grade corporate bond market, depending on their investment objectives and risk tolerance.
Readmoreless
iShares iBoxx $ High Yield Corporate Bond ETF (HYG)
Trend
Range $79.65 - $79.83
The iShares iBoxx $ High Yield Corporate Bond ETF (HYG) is designed to mirror a broad index of U.S. dollar-denominated high-yield corporate bonds, giving investors access to potentially higher returns and diversification. HYG holds over 1,000 bonds across various sectors and credit ratings, with substantial allocations in the 3–5-year and 5–7-year maturity ranges. The fund has delivered a 1-year return of 4.35%, a 12-month dividend yield of 5.88%, and a low expense ratio of 0.49%, making it appealing to income-focused investors. While HYG carries moderate risk due to higher credit risk and high-yield bond volatility, its potential for enhanced returns and lower correlation with other fixed-income and equity markets can improve overall portfolio diversification and risk-return balance.
Readmoreless
Vanguard Short-Term Corporate Bond Index (VCSH)
Trend
Range $78.45 - $78.57
The Vanguard Short-Term Corporate Bond Index (VCSH) focuses on high-quality corporate bonds with maturities of 1 to 5 years. Its primary goal is to provide investors with stable, moderate current income while minimising exposure to interest rate risk. The fund closely tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, which reflects the performance of U.S. dollar-denominated, investment-grade, fixed-rate bonds issued by companies in the industrial, utility, and financial sectors. With a remarkably low expense ratio of 0.03%, far below the industry average, VCSH has consistently outperformed its benchmark. The fund has delivered one-year returns of 2.79% and a 12-month dividend yield of 4.47%. It is well-diversified across various sectors, including financials, consumer non-cyclical, communications, and technology.
Readmoreless

Data Source: Bloomberg
Date: 31st August, 2026

Arun Leslie John
Chief Market Analyst

Deepa Sachanandani
Deputy Head - Research

icon
The product and investment ideas do not consider the risk profile and financial position of the recipient and may not be suitable for everyone.
Trading in financial markets involves a significant risk of loss, which can exceed deposits. Please read the complete disclaimer carefully.
DISCLAIMER: Century Financial Consultancy LLC (“CFC”) is Limited Liability Company incorporated under the Laws of UAE and is duly licensed and regulated by the Emirates Securities and Commodities Authority of UAE (SCA). This information is for illustrative proposes only and must not be construed to be an advice to invest or otherwise in any investment or financial product. CFC does not guarantee as to adequacy, accuracy, completeness or reliability of any information or data contained herein and under no circumstances whatsoever none of such information or data be construed as an advice or trading strategy or recommendation to deal (Buy/Sell) in any investment or financial product. CFC is not responsible or liable for any result, gain or loss, based on this information, in whole or in part. Please refer to the disclaimer section of the website for full disclosure of the terms and conditions.
Risks & Assumptions
icon
The strategy might suffer from look-ahead bias which occurs due to use of information or data in a study or simulation that would not have been known or available during the period being analyzed. This can lead to inaccurate results in the study or simulation.
icon
Future price movements may not be exactly the same as the historical price movements and this could lead to variation in performance.
icon
Testing can sometimes lead to over-optimization. This is a condition where performance results are tuned so high to the past they are no longer as accurate in the future.
icon
The model assumes no slippages in trading. Slippage refers to the difference between the expected price of a trade and the price at which the trade is actually executed.
icon
Drawdowns in actual trading can be higher than the tested system and loses could significant in the event of leverage.
icon
Unforeseen events can lead to variation in performance from the tested trading strategy.
icon
The tested result has been computed with price feeds available from Bloomberg.
icon
The testing environment has not considered transaction or any other costs.
icon
Trading indicators used for the purpose of testing has been provided by Bloomberg.
icon
The strategy might suffer from data mining fallacy, selection bias and backfill bias.